Replies to post #32671 on Marker Therapeutics Inc (MRKR)

[GMA13]

If MRKR’s science (finally) delivers stellar & robust test results, a $3+++ PPS is a very simple accomplishment.
I too go back to investing in the legacy TPIV. Then, I harvested a needed tax loss 2 times & finally bought back at the Nov & Dec 2022 lows. So I am reasonably okay here unless they go bust.